Company: CCIXW
Filing Date: 2025-12-05
Form Type: S-4/A
Source: 0001193125-25-309933
Chunk: 319

Company: Churchill Capital Corp IX/Cayman
Filing Date: 2025-12-05
Form: S-4/A
Chunk 319
---
000,001 of net tangible assets as a result of the holders of CCIX public shares properly demanding redemption of their shares for cash, CCIX will not be able to consummate the business combination. The closing price of CCIX public shares on , 2025, the record date for the extraordinary general meeting, was $ per share. The cash held in the trust account on such date was approximately $ (approximately $ per CCIX public share outstanding as of the record date). Prior to exercising redemption rights, shareholders should verify the market price of CCIX public shares as they may receive higher proceeds from the sale of their shares in the public market than from exercising their redemption rights if the market price per share is higher than the redemption price. CCIX cannot assure its shareholders that they will be able to sell CCIX public shares in the open market, even if the market price per share is higher than the redemption price stated above, as there may not be sufficient liquidity in its securities when its shareholders wish to sell their shares. If a holder of CCIX public shares properly exercises its redemption rights and the business combination is consummated, then they will be exchanging their CCIX public shares for cash and will no longer own those shares. They will be entitled to receive cash for their CCIX public shares only if they properly exercise their redemption rights no later than the Redemption Deadline by delivering their certificate (either physically or electronically) to CCIX’s transfer agent prior to the Redemption Deadline. Sources and Uses of Funds for the Transactions The following tables summarize the sources and uses for funding the Transactions under the following scenarios: No Redemptions Scenario These figures assume that (1) no public shareholders exercise their redemption rights in connection with the Transactions, (2) the Post-Closing Company issues 113,036,645 shares of Post-Closing Company common stock to PlusAI stockholders (which includes holders of PlusAI preferred stock, PlusAI common stock, and PlusAI SAFEs, that, pursuant to the Conversion, are converted to PlusAI common stock immediately prior to the Merger) and (3) there has been no additional incremental financing raised by PlusAI. If the actual facts are different from these assumptions, then the amounts and shares outstanding after the Closing will be different and those changes could be material.

|                                       |     | Sources         
 ($ in millions) |         |     |                                      |     | Uses            
 ($ in millions) |         |
|:--------------------------------------|:----|:----------------|--------:|:----|:-------------------------------------|: